Affimed to Participate in Investor Conferences in September
August 28 2019 - 5:00AM
Heidelberg, Germany, August 28, 2019 - Affimed
N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company
committed to giving patients back their innate ability to fight
cancer, today announced its participation in the following upcoming
investor conferences in September:
- Wells Fargo Securities 2019 Healthcare
Conference. Affimed’s Chief Executive Officer, Dr. Adi
Hoess, will present on Wednesday, September 4, 2019 at 9:05 a.m.
Eastern Time.
- Citi's 14th Annual Biotech Conference. Affimed
will host meetings with investors at the conference on Thursday,
September 5, 2019.
A live webcast of the presentation at the Wells
Fargo Securities 2019 Healthcare Conference can be accessed in the
“Webcasts” section on the “Investors” page of the Affimed website
at https://www.affimed.com/investors/webcasts/ and will be
available for 30 days following the event.
About Affimed N.V.
Affimed (Nasdaq: AFMD) is a clinical stage
biopharmaceutical company committed to giving patients back their
innate ability to fight cancer. Affimed’s fit-for-purpose ROCK®
platform allows innate cell engagers to be designed for specific
patient populations. The Company is developing single and
combination therapies to treat hematologic and solid tumors. For
more information, please visit www.affimed.com.
Affimed Investor
Contact:Gregory Gin, Head of Investor RelationsE-Mail:
IR@affimed.com
Affimed Media Contact:Anca
Alexandru, Head of Communications, EU IR
E-Mail: media@affimed.com
Affimed NV (NASDAQ:AFMD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Affimed NV (NASDAQ:AFMD)
Historical Stock Chart
From Apr 2023 to Apr 2024